References
- Kuendgen A, Strupp C, Aivado M, Bernhardt A, Hildebrandt B, Hass R, et al. Treatment of myelodysplastic syndromes with valproic acid alone or in combination with all-trans retinoic acid. Blood 2004; 104: 1266–9
- Pilatrino C, Cilloni D, Messa E, Morotti A, Giugliano E, Pautasso M, et al. Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid. Cancer 2005; 104: 101–9
- Bug G, Ritter M, Wassmann B, Schoch C, Heinzel T, Schwarz K, et al. Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia (AML). Cancer 2005; 104: 2717–25
- Raffoux E, Chaibi P, Dombret H, Degos L. Valproic acid and all-trans retinaoic acid for the treatment of elderly patients with acute myebid leukemia. Haematologica 2005; 90: 986–8
- Zhou DC, Kim SH, Ding W, Schultz C, Warrell RP, Jr, Gallagher RE. Frequent mutations in the ligand-binding domain of PML-RARalpha after multiple relapses of acute promyelocytic leukemia: Analysis for functional relationship to response to all-trans retinoic acid and histone deacetylase inhibitors in vitro and in vivo. Blood 2002; 99: 1356–63
- Yang XJ, Gregoire S. Class II histone deacetylases: From sequence to function, regulation, and clinical implication. Mol Cell Biol 2005; 25: 2873–84
- Seiter K, Feldman EJ, Dorota Halicka H, Deptala A, Traganos F, Burke HB, et al. Clinical and laboratory evaluation of all-trans retinoic acid modulation of chemotherapy in patients with acute myelogenous leukaemia. Br J Haematol 2000; 108: 40–7
- Guillemin MC, Raffoux E, Vitoux D, Kogan S, Soilihi H, Lallemand-Breitenbach V, et al. In vivo activation of cAMP signalling induces growth arrest and differentiation in acute promyelocytic leukemia. J Exp Med 2002; 196: 1373–80
- Ryningen, A, Apelseth, T, Hausken, T, Burserud, Ø. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy. Platelets 2006, in press.
- Chaoui D, Chakroun T, Robert F, Rio B, Belhocine R, Legrand O, et al. Reticulated platelets: A reliable measure to reduce prophylactic platelet transfusions after intensive chemotheray. Transfusion 2005; 45: 766–72
- Huo X, Zhang J. Important roles of reversible acetylation in the function of hematopoietic transcription factors. J Cell Mol Med 2005; 9: 103–12
- Bug G, Gul H, Schwarz K, Pfeifer H, Kampfmann M, Zheng X, et al. Valproic acid stimulates proliferation and self-renewal of hematopoietic stem cells. Cancer Res 2005; 65: 2537–41